Lindpaintner K - Search Results

1

Pharmacogenetic analysis of adverse drug effect reveals genetic variant for susceptibility to liver toxicity.

Acuña G, Foernzler D, Leong D, Rabbia M, Smit R, Dorflinger E, Gasser R, Hoh J, Ott J, Borroni E, To Z, Thompson A, Li J, Hashimoto L, Lindpaintner K. Acuña G, et al. Among authors: lindpaintner k. Pharmacogenomics J. 2002;2(5):327-34. doi: 10.1038/sj.tpj.6500123. Pharmacogenomics J. 2002. PMID: 12439739

2

The importance of being modest--reflections on the pharmacogenetics of abacavir.

Lindpaintner K. Lindpaintner K. Pharmacogenomics. 2002 Nov;3(6):835-8. doi: 10.1517/14622416.3.6.835. Pharmacogenomics. 2002. PMID: 12437485 Review. No abstract available.

3

Pharmacogenetics and the future of medical practice: conceptual considerations.

Lindpaintner K. Lindpaintner K. Pharmacogenomics J. 2001;1(1):23-6. doi: 10.1038/sj.tpj.6500009. Pharmacogenomics J. 2001. PMID: 11913723 No abstract available.

4

Selecting SNPs in two-stage analysis of disease association data: a model-free approach.

Hoh J, Wille A, Zee R, Cheng S, Reynolds R, Lindpaintner K, Ott J. Hoh J, et al. Among authors: lindpaintner k. Ann Hum Genet. 2000 Sep;64(Pt 5):413-7. doi: 10.1046/j.1469-1809.2000.6450413.x. Ann Hum Genet. 2000. PMID: 11281279

5

Lack of association between the SOST gene and bone mineral density in perimenopausal women: analysis of five polymorphisms.

Balemans W, Foernzler D, Parsons C, Ebeling M, Thompson A, Reid DM, Lindpaintner K, Ralston SH, Van Hul W. Balemans W, et al. Among authors: lindpaintner k. Bone. 2002 Oct;31(4):515-9. doi: 10.1016/s8756-3282(02)00844-x. Bone. 2002. PMID: 12398949

6

Statistical methods for analyzing microarray feature data with replications.

Yang Y, Hoh J, Broger C, Neeb M, Edington J, Lindpaintner K, Ott J. Yang Y, et al. Among authors: lindpaintner k. J Comput Biol. 2003;10(2):157-69. doi: 10.1089/106652703321825946. J Comput Biol. 2003. PMID: 12804089

7

Genetics in drug discovery and development: challenge and promise of individualizing treatment in common complex diseases.

Lindpaintner K. Lindpaintner K. Br Med Bull. 1999;55(2):471-91. doi: 10.1258/0007142991902385. Br Med Bull. 1999. PMID: 10723870 Review. No abstract available.

8

The impact of pharmacogenetics and pharmacogenomics on drug discovery.

Lindpaintner K. Lindpaintner K. Nat Rev Drug Discov. 2002 Jun;1(6):463-9. doi: 10.1038/nrd823. Nat Rev Drug Discov. 2002. PMID: 12119748 Review.

9

Pharmacogenetics and pharmacogenomics.

Lindpaintner K. Lindpaintner K. Methods Mol Med. 2005;108:235-60. doi: 10.1385/1-59259-850-1:235. Methods Mol Med. 2005. PMID: 16028688

10

Molecular genetics of pseudoxanthoma elasticum: type and frequency of mutations in ABCC6.

Miksch S, Lumsden A, Guenther UP, Foernzler D, Christen-Zäch S, Daugherty C, Ramesar RK, Lebwohl M, Hohl D, Neldner KH, Lindpaintner K, Richards RI, Struk B. Miksch S, et al. Among authors: lindpaintner k. Hum Mutat. 2005 Sep;26(3):235-48. doi: 10.1002/humu.20206. Hum Mutat. 2005. PMID: 16086317

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

188 results

Search Page

Filters